סטוקרין 600 מ"ג טבליות
merck sharp & dohme israel ltd - efavirenz 600 mg - film coated tablets - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .
סטוקרין 600 מג טבליות
merck sharp & dohme (israel - 1996) company ltd, israel - efavirenz - טבליות מצופות פילם - efavirenz 600 mg - efavirenz - efavirenz - stocrin in combination with other antiretroviral agents, is indicated for the treatment of hiv-1-infection .
אדוראנט
j-c health care ltd - rilpivirine as hydrochloride - טבליה - rilpivirine as hydrochloride 25 mg - rilpivirine - rilpivirine - edurant in combination with other antiretroviral agents for the treatment of hiv-1 infection in treatment-na?ve adult patients.
אוויפלרה
j-c health care ltd - emtricitabine; rilpivirine as hydrochloride; tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg; rilpivirine as hydrochloride 25 mg; emtricitabine 200 mg - rilpivirine - rilpivirine - eviplera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is indicated for use as a complete regimen for the treatment of hiv-1 infection in antiretroviral treatment-naive adults. this indication is based on week 48 safety and efficacy analyses from 2 randomized, double-blind, active controlled, phase 3 trials in treatment-naive subjects comparing rilpivirine to efavirenz . the following points should be considered when initiating therapy with eviplera: -more rilpivirine-treated subjects with hiv-1 rna greater than 100,000 copies/ml at the start of therapy experienced virologic failure compared to subjects with hiv-1 rna less than 100,000 copies/ml at the start of therapy. -the observed virologic failure rate in rilpivirine-treated subjects conferred a higher rate of overall treatment resistance and cross-resistance to the nnrti class compared to efavirenz . -more subjects treated with rilpivirine developed lamivudine/emtricitabine associated resistance compared to efavirenz. -eviplera is not recomme
אוויפלרה
j-c health care ltd - emtricitabine; rilpivirine as hydrochloride; tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg; rilpivirine as hydrochloride 25 mg; emtricitabine 200 mg - rilpivirine - rilpivirine - eviplera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is indicated for use as a complete regimen for the treatment of hiv-1 infection in antiretroviral treatment-naive adults. this indication is based on week 48 safety and efficacy analyses from 2 randomized, double-blind, active controlled, phase 3 trials in treatment-naive subjects comparing rilpivirine to efavirenz . the following points should be considered when initiating therapy with eviplera: -more rilpivirine-treated subjects with hiv-1 rna greater than 100,000 copies/ml at the start of therapy experienced virologic failure compared to subjects with hiv-1 rna less than 100,000 copies/ml at the start of therapy. -the observed virologic failure rate in rilpivirine-treated subjects conferred a higher rate of overall treatment resistance and cross-resistance to the nnrti class compared to efavirenz . -more subjects treated with rilpivirine developed lamivudine/emtricitabine associated resistance compared to efavirenz. -eviplera is not recomme
סלסנטרי 150 מג
glaxo smith kline (israel) ltd - maraviroc - טבליות מצופות פילם - maraviroc 150 mg - maraviroc - maraviroc - celsentri is a ccr5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only ccr5-tropic hiv-1.• in treatment-na?ve subjects, more subjects treated with celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• tropism testing with a highly sensitive tropism assay is required for the appropriate use of celsentri.
סלסנטרי 300 מג
glaxo smith kline (israel) ltd - maraviroc - טבליות מצופות פילם - maraviroc 300 mg - maraviroc - maraviroc - celsentri is a ccr5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only ccr5-tropic hiv-1.• in treatment-na?ve subjects, more subjects treated with celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.• tropism testing with a highly sensitive tropism assay is required for the appropriate use of celsentri.
קבותרים 2
trima israel pharmaceutical products maabarot ltd - cabergoline - טבליה - cabergoline 2 mg - cabergoline - cabergoline - parkinson's disease. combination therapy with l-dopa and as monotherapy for newly diagnosed illness.
קיווקסה
glaxo smith kline (israel) ltd - abacavir as sulfate; lamivudine - טבליות מצופות פילם - abacavir as sulfate 600 mg; lamivudine 300 mg - nucleoside and nucleotide reverse transcriptase inhibitors - kivexa is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.
גביסקון נוזל מנטה
reckitt benckiser (near east) ltd - alginic acid as sodium; calcium carbonate; sodium bicarbonate - תרחיף - alginic acid as sodium 50 mg/ml; sodium bicarbonate 26.7 mg/ml; calcium carbonate 16 mg/ml - alginic acid - salt solutions - gastro reflux, heartburn, flatulence associated with gastric reflux, heartburn of pregnancy, all cases of epigastric and retrosternal distress where the underlying cause is gastric reflux.